BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 17142321)

  • 1. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.
    Zhou D; Srivastava R; Nessler S; Grummel V; Sommer N; Brück W; Hartung HP; Stadelmann C; Hemmer B
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19057-62. PubMed ID: 17142321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
    Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Stefferl A; Brehm U; Linington C
    J Neural Transm Suppl; 2000; (58):123-33. PubMed ID: 11128602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary: Sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire.
    Mathey E; Breithaupt C; Schubart AS; Linington C
    Eur J Immunol; 2004 Aug; 34(8):2065-71. PubMed ID: 15259003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
    Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
    Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Iglesias A; Bauer J; Litzenburger T; Schubart A; Linington C
    Glia; 2001 Nov; 36(2):220-34. PubMed ID: 11596130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.
    Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
    Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
    Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.
    Matsumoto Y; Park IK; Hiraki K; Ohtani S; Kohyama K
    Immunology; 2009 Sep; 128(1 Suppl):e250-61. PubMed ID: 19175799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls.
    Haase CG; Guggenmos J; Brehm U; Andersson M; Olsson T; Reindl M; Schneidewind JM; Zettl UK; Heidenreich F; Berger T; Wekerle H; Hohlfeld R; Linington C
    J Neuroimmunol; 2001 Mar; 114(1-2):220-5. PubMed ID: 11240035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein.
    O'Connor KC; Appel H; Bregoli L; Call ME; Catz I; Chan JA; Moore NH; Warren KG; Wong SJ; Hafler DA; Wucherpfennig KW
    J Immunol; 2005 Aug; 175(3):1974-82. PubMed ID: 16034142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
    Genain CP; Nguyen MH; Letvin NL; Pearl R; Davis RL; Adelman M; Lees MB; Linington C; Hauser SL
    J Clin Invest; 1995 Dec; 96(6):2966-74. PubMed ID: 8675668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides.
    Ichikawa M; Johns TG; Adelmann M; Bernard CC
    Int Immunol; 1996 Nov; 8(11):1667-74. PubMed ID: 8943561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in Multiple Sclerosis.
    Berger T; Reindl M
    J Neural Transm Suppl; 2000; (60):351-60. PubMed ID: 11205153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH; Linker RA
    Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
    O'Connor KC; McLaughlin KA; De Jager PL; Chitnis T; Bettelli E; Xu C; Robinson WH; Cherry SV; Bar-Or A; Banwell B; Fukaura H; Fukazawa T; Tenembaum S; Wong SJ; Tavakoli NP; Idrissova Z; Viglietta V; Rostasy K; Pohl D; Dale RC; Freedman M; Steinman L; Buckle GJ; Kuchroo VK; Hafler DA; Wucherpfennig KW
    Nat Med; 2007 Feb; 13(2):211-7. PubMed ID: 17237795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
    Pacini G; Ieronymaki M; Nuti F; Sabatino G; Larregola M; Aharoni R; Papini AM; Rovero P
    J Pept Sci; 2016 Jan; 22(1):52-8. PubMed ID: 26663200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
    Weissert R; Kuhle J; de Graaf KL; Wienhold W; Herrmann MM; Müller C; Forsthuber TG; Wiesmüller KH; Melms A
    J Immunol; 2002 Jul; 169(1):548-56. PubMed ID: 12077287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis.
    Guggenmos J; Schubart AS; Ogg S; Andersson M; Olsson T; Mather IH; Linington C
    J Immunol; 2004 Jan; 172(1):661-8. PubMed ID: 14688379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.